← Back to Analyst Consensus 
GRI Buy
GRI Bio, Inc.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 21, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Jun 1, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Mar 11, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 8, 2025 | Ascendiant Capital | maintain | Buy → Buy | $36 | 38% |
| Sep 22, 2025 | Ascendiant Capital | maintain | Buy → Buy | $35 | 38% |
| Jun 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 27, 2025 | Ascendiant Capital | maintain | Buy → Buy | $34 | 38% |
| Apr 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Dec 9, 2024 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Dec 5, 2024 | Ascendiant Capital | maintain | Buy → Buy | $13 | 38% |
Price Target Trend
Apr 20, 2026 Latest: $18.5 Oct 23, 2026
EPS Estimates
0q $-0.84
Lo: $-0.93 Hi: $-0.75
2 analysts +1q $-0.82
Lo: $-0.91 Hi: $-0.74
2 analysts +1y $-2.00
Lo: $-3.79 Hi: $-0.21
2 analysts ▲1
0y $-3.90
Lo: $-4.13 Hi: $-3.66
2 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days